They also said that spectinomycin was an effective and useful treatment option for people who could not tolerate cephalosporins, however it is a costly, injectable drug which is not available in the USA therefore this antibiotic was not included in the CDC guidelines recommendations.
Además, señalan que si bien la espectinomicina es efectiva y una opción de tratamiento útil en personas que no toleran las cefalosporinas, es un medicamento costoso, inyectable y que no está disponible en Estados Unidos por lo tanto no la incluyen en las recomendaciones.